Ascletis Pharma Inc. (ASCLF)
USD 0.24
(0.0%)
USD 0.24
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -144.16 Million | -142.45 Million | -146.93 Million | -84.91 Million | -74.34 Million | -96.59 Million |
| Net Income | -144.71 Million | -314.84 Million | -199.01 Million | -209.24 Million | -95.96 Million | -19.87 Million |
| Depreciation & Amortization | 18.48 Million | 30.19 Million | 29.54 Million | 27.16 Million | 22.14 Million | 11.98 Million |
| Deferred income taxes | - | 148.89 Million | 47.53 Million | 122.46 Million | 76.66 Million | -1.8 Million |
| Stock-based compensation | 1.33 Million | 3.19 Million | 7.13 Million | 4.61 Million | 3.12 Million | 4.26 Million |
| Change in working capital | 34.45 Million | 33.8 Million | -10.17 Million | 10.42 Million | -8.41 Million | -66.15 Million |
| Other non-cash items | -98.83 Million | -43.69 Million | -21.95 Million | -40.33 Million | -71.89 Million | -25 Million |
| Investing Cash Flow | 149.84 Million | -1.29 Billion | -274.49 Million | 132.29 Million | 602.26 Million | -817.47 Million |
| Investments in PPE | -19.15 Million | -14.4 Million | -7.19 Million | -38.96 Million | -28.23 Million | -60.08 Million |
| Acquisitions | - | 7.33 Million | 2.23 Million | -19.65 Million | -67.4 Million | 44.26 Million |
| Investment purchases | -997.22 Million | -1.76 Billion | -601.97 Million | -75.41 Million | 9.34 Million | -1.13 Billion |
| Sales/Maturities of investments | 1.16 Billion | 479.32 Million | 332.2 Million | 190.61 Million | 697.23 Million | 372 Million |
| Other Investing Activities | 156.05 Million | -7.23 Million | 254 Thousand | 75.71 Million | -8.68 Million | -41.07 Million |
| Financing Cash Flow | -81.49 Million | -1.41 Million | -31.09 Million | -21.67 Million | -48.21 Million | 2.56 Billion |
| Debt repayment | -2.39 Million | -2.22 Million | -2.28 Million | -1.93 Million | -1.94 Million | - |
| Dividends payments | - | - | - | - | - | -57.81 Million |
| Common Stock Repurchased | -78.96 Million | - | -28.68 Million | -19.6 Million | -46.26 Million | - |
| Common Stock Issuance | - | 961 Thousand | - | - | - | 2.97 Billion |
| Other Financing Activities | -144 Thousand | -2.38 Million | -2.4 Million | -2.06 Million | -1.94 Million | -352.82 Million |
| Accounts receivables | 18.44 Million | 29.74 Million | -26.99 Million | 42.98 Million | -11.9 Million | -57.62 Million |
| Accounts payables | - | -29.74 Million | 26.99 Million | -42.98 Million | 11.9 Million | - |
| Inventory | -8.05 Million | -12.83 Million | -5.06 Million | -18.37 Million | -2.16 Million | -21.66 Million |
| Other working capital | 28.13 Million | 46.64 Million | -5.1 Million | 28.79 Million | -6.25 Million | -44.49 Million |
| Cash at beginning of period | 403.76 Million | 1.72 Billion | 2.21 Billion | 2.29 Billion | 1.78 Billion | 123.69 Million |
| Cash at end of period | 330.11 Million | 403.76 Million | 1.72 Billion | 2.21 Billion | 2.29 Billion | 1.78 Billion |
| Capital Expenditure | -19.15 Million | -14.4 Million | -7.19 Million | -38.96 Million | -28.23 Million | -60.08 Million |
| Effect of forex changes on cash | 2.16 Million | 117.61 Million | -30.57 Million | -110.25 Million | 33.44 Million | 12.11 Million |
| Net cash flow / Change in cash | -73.65 Million | -1.32 Billion | -483.09 Million | -84.54 Million | 513.15 Million | 1.65 Billion |
| Free Cash Flow | -163.32 Million | -156.85 Million | -154.12 Million | -123.87 Million | -102.57 Million | -156.67 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -144.71 Million | -17.72 Million | -2.38 Million | -314.84 Million | -32.58 Million | -13.53 Million |
| Depreciation & Amortization | 18.48 Million | 1.36 Million | 1.28 Million | 30.19 Million | 2.21 Million | 2.31 Million |
| Deferred income taxes | - | - | - | 148.89 Million | - | - |
| Stock-based compensation | 1.33 Million | - | - | 3.19 Million | - | - |
| Change in working capital | 34.45 Million | 6.46 Million | -1.69 Million | 33.8 Million | 5.64 Million | -782.27 Thousand |
| Other non-cash items | -98.83 Million | 3.06 Million | -6.06 Million | -43.69 Million | 15.55 Million | 7.1 Million |
| Investing Cash Flow | 149.84 Million | 770.11 Thousand | 19.88 Million | -1.29 Billion | -89.76 Million | -96.12 Million |
| Investments in PPE | -19.15 Million | -2.35 Million | -297.35 Thousand | -14.4 Million | -177.12 Thousand | -1.88 Million |
| Acquisitions | - | 16.42 Thousand | 721.38 | 7.33 Million | - | - |
| Investment purchases | -997.22 Million | -64.95 Million | -72.71 Million | -1.76 Billion | -132.94 Million | -119.62 Million |
| Sales/Maturities of investments | 1.16 Billion | 68.05 Million | 92.89 Million | 479.32 Million | 43.34 Million | 25.38 Million |
| Other Investing Activities | 156.05 Million | - | -1.38 | -7.23 Million | 13.21 Thousand | -1.00 |
| Financing Cash Flow | -81.49 Million | -9.62 Million | -1.64 Million | -1.41 Million | -188.98 Thousand | -14.76 Thousand |
| Debt repayment | -2.39 Million | - | - | -2.22 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -78.96 Million | -9.46 Million | -1.44 Million | - | - | - |
| Common Stock Issuance | - | - | - | 961 Thousand | -10.51 Thousand | 147.83 Thousand |
| Other Financing Activities | -144 Thousand | - | -195.49 Thousand | -2.38 Million | -178.46 Thousand | - |
| Accounts receivables | 18.44 Million | -90.42 Thousand | 2.63 Million | 29.74 Million | 4.84 Million | -566.89 Thousand |
| Accounts payables | - | -896.68 Thousand | 550.84 Thousand | -29.74 Million | -459.28 Thousand | 754.58 Thousand |
| Inventory | -8.05 Million | -114.46 Thousand | -995.93 Thousand | -12.83 Million | -975.12 Thousand | -864.88 Thousand |
| Other working capital | 28.13 Million | 7.56 Million | -3.87 Million | 46.64 Million | 2.23 Million | -105.07 Thousand |
| Cash at beginning of period | 403.76 Million | 345.83 Million | 355.11 Million | 1.72 Billion | 370.9 Million | 391.44 Million |
| Cash at end of period | 330.11 Million | 320.62 Million | 345.83 Million | 403.76 Million | 355.11 Million | 370.9 Million |
| Capital Expenditure | -19.15 Million | -2.35 Million | -297.35 Thousand | -14.4 Million | -177.12 Thousand | -1.88 Million |
| Effect of forex changes on cash | 2.16 Million | - | -18.26 Million | 117.61 Million | 84.36 Million | 85.81 Million |
| Net cash flow / Change in cash | -73.65 Million | -25.21 Million | -9.27 Million | -1.32 Billion | -15.79 Million | -20.53 Million |
| Free Cash Flow | -163.32 Million | -13.01 Million | -9.54 Million | -156.85 Million | -10.37 Million | -12.09 Million |
BKHPF
7031
3988
CVONF
VNRFY
002895